The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I mean you've identified the problems the hype and the commercialization. I mean commercialization can be helpful if the the companies are actually willing to invest in clinical trials and so on. You know, I always use the example of timeline uralithn a I mean there we've worked with them they do clinical trials rigorous there you know we they publish them in in the best journals and at the end you know what you're measuring and and so
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.